处方家庭数字温度计与活动剂量和优化卸载相结合,以延长糖尿病足缓解:一个案例报告
Malindu E Fernando1,2,3,4, Virginie Blanchette5,6, Stephanie L Woelfel7
1Southwestern Academic Limb Salvage Alliance (SALSA), Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
The international journal of lower extremity wounds
|July 4, 2023
概括
糖尿病足 (DFU) 缓解需要谨慎的活动管理. 以患者为中心的方法,使用脚部温度监测和剂量活动,可以减少复发并改善生活质量.
科学领域:
- 足部医学是一门专业.
- 糖尿病学 糖尿病学
- 康复医学 康复医学 康复医学
背景情况:
- 糖尿病足 (DFU) 显著损害生活质量,并具有高的每年复发风险.
- 对复发的恐惧导致缓解期的身体活动减少,矛盾地增加了对创伤的易感性.
- 目前的指导方针缺乏关于DFU缓解期间体育活动水平的具体建议.
研究的目的:
- 描述一种以患者为中心的方法来管理DFU缓解期的身体活动.
- 为了整合家庭足部温度监测,每日足部检查和剂量活动.
- 探索患者对这种干预措施的看法.
主要方法:
- 一个案例研究描述了以患者为中心的DFU缓解管理计划的实施.
- 包括在家进行脚部温度监测.
- 整合每日脚部检查和结构化,剂量恢复体力活动.
主要成果:
- 描述的方法旨在优化无的日子,并提高DFU病史患者的生活质量.
- 有证据表明,家庭足部温度监测和活动修改可以减少50%的复发.
结论:
- 以患者为中心,剂量活动的方法与监测相结合,有望防止DFU复发.
- 这一策略可以改善DFU缓解期患者的长期结果和生活质量.
相关概念视频
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Peripheral Artery Disease IV: Nursing Management
12
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
12
Insulin: Dosing Regimen and Adverse Effects
213
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.2K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.2K
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K


